Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus melatonin versus placebo for insomnia in children with anxiety disorders
IRCT20220820055756N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of clonidine and melatonin in Insomnia and anxiety disorder (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Sleep quality of children with anxiety disorders. Started Sep 2022; status: completed.
02
Drugs
clonidinemelatonin
03
Conditions
Insomniaanxiety disorder
Beyond the preview
Go deeper on IRCT20220820055756N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220820055756N1.